A new opinion piece argues that AI must pivot toward solving critical medical challenges like cancer. The author claims current development focuses too heavily on trivial applications. This critique highlights a growing tension between commercial AI utility and high-impact biomedical research. Practitioners should expect increased pressure to align large-scale models with urgent healthcare outcomes.